Based on this YouTube video's total view count of 354K views and industry-standard rates, the estimated total earning is $248 - $708 through ad revenue. Historical data is not yet available to calculate daily, weekly, or monthly averages.

Explore Prevalence remains high with 354,159 views, 9,971 likes, and 1,972 comments. Experience the impact of this video content that has captured audience attention.

California, SMARTER Plan https://files.covid19.ca.gov/pdf/smarterplan.pdf The release of the California SMARTER Plan: The Next Phase of California’s COVID-19 Response It is clear the virus will remain with us for some time, if not forever. However, we know what works, and have built the necessary tools over the last two years that allows us to learn and hone our defenses to this virus as it evolves. As we enter the next phase with COVID-19, which may include future surges and new variants, In our approach to this next phase, we will be smarter than ever before, using the lessons of the last two years to approach mitigation and adaptation measures This includes vaccines, masks, tests, quarantine, improving ventilation, and new therapeutics. But California’s path forward will also be predicated on our individual, smarter actions, that will collectively yield better outcomes for our neighborhoods, communities, and state. Shots- Vaccines are the most powerful weapon against hospitalization and serious illness. Masks- Properly worn masks with good filtration help slow the spread of COVID-19 or other respiratory viruses. Awareness- We will continue to stay aware of how COVID-19 is spreading, evolving variants, communicate clearly how people should protect themselves, and coordinate our state and local government response. Readiness- COVID-19 isn’t going away and we need to be ready with the tools, resources and supplies we will need to quickly respond and keep public health and the health care system well prepared. Testing- Getting the right type of tests - PCR or antigen - to where they are needed most. Testing will help California minimize the spread of COVID-19. Education- California will continue to work to keep schools open and children safely in classrooms for in-person instruction. Rx- Evolving and improving treatments will become increasingly available and critical as a tool to save lives. Zoe data https://covid.joinzoe.com UK R = 0.9 England, 0.9 Wales, 1.0 Scotland, 1.1 Prevalence UK,1 in 25 have symptomatic COVID ONS, 1 in 20 in England At least 36.7% of cold-like symptoms are likely to have symptomatic COVID-19 Professor Tim Spector cases remain historically high with one in 25 people currently having COVID, and numbers still increasing in Scotland and Northern Ireland. hospital and ICU admissions are very low, the ZOE data doesn’t yet suggest that we’ve entered a stable or endemic phase. déjà vu my advice is we should all still be self isolating for five days from first new symptoms, when infectiousness is high NSW Government update to COVID-19 settings https://www.nsw.gov.au/media-releases/nsw-government-update-to-covid-19-settings Easing of restrictions, 18th and 25th February Hospitalisation and ICU rates easing Booster uptake now above 50% Staged return of non-urgent elective surgery across all NSW public hospitals Minister for Health Brad Hazzard As we are moving more into the endemic stage of the COVID-19 pandemic, The best outcome is still to avoid getting the virus by protecting yourself, your family, and the broader community Novavax – first protein vaccine now available https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/novavax-first-protein-vaccine-now-available https://www.health.gov.au/news/atagi-statement-on-the-use-of-novavax-covid-19-vaccine-nuvaxovid Australian Technical Advisory Group on Immunisation ATAGI recommends that Novavax COVID-19 vaccine can be used for the primary course of COVID-19 vaccination in people aged 18 or older. Novavax COVID-19 vaccine can be administered to pregnant and breastfeeding women. People with severe immunocompromise are recommended to receive 3 primary doses of COVID-19 vaccine, and Novavax COVID-19 vaccine can be used Heterologous use not currently recommended for use as a booster vaccine can be co-administered with other vaccines if required. Myocarditis it is not possible to determine if there is a causal relationship or to estimate the risk of myocarditis associated with this vaccine. It is recommended that all COVID-19 vaccine recipients should be aware of the potential signs and symptoms of myocarditis or pericarditis, and should be counselled about when to seek medical attention.

With SocialCounts.org’s view counter, track your YouTube video’s live view count and YouTube likes count in real time with fast, reliable updates.

Watch every YouTube video live view count rise with our real-time YouTube views tracker—built for accuracy and minimal delay.

Follow YouTube real time views as they happen, using our dedicated view counter for YouTube videos.

Get up-to-date live view count on YouTube and see real-time growth with SocialCounts.org’s smart tracking tools.